Advaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at the ASCO Genitourinary Cancers Symposium

Ads

You May Also Like

Highly Anticipated Multiple Sclerosis Medicine Offers New Hope

MISSION, KS--(Marketwired - Apr 10, 2017) -  (Family Features) Multiple sclerosis (MS) is a ...

ThromboGenics Business Update – Q3 2017

Press release                                                          20 October, 2017Regulated Information Diabetic Eye Disease programs progressing €53.7 million cash ...